In an MPTP mouse model of PD, treatment of Ex-4 systemically prevented microglial activation induced by MPTP and release of pro-inflammatory mediators such as TNFα and IL-1β, suggesting Ex-4's role as a potential therapeutic in neurodegenerative diseases (Kim et al., 2009). This evidence concerns the gene TNF and Parkinson disease.